Balyasny Asset Management LLC Avid Bioservices, Inc. Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.7 - $12.45 $520,971 - $968,074	77,757 Added 230.16%	111,541 $1.27 Million
Q2 2024 Aug 14, 2024	BUY	$6.34 - $9.28 $214,190 - $313,515	33,784 New	33,784 $241,000
Q3 2023 Nov 14, 2023	SELL	$9.4 - $14.04 $1.55 Million - $2.31 Million	-164,618 Reduced 85.44%	28,061 $264,000
Q2 2023 Aug 14, 2023	BUY	$12.96 - $20.93 $2.5 Million - $4.03 Million	192,679 New	192,679 $2.69 Million
Q2 2021 Aug 16, 2021	SELL	$18.93 - $25.65 $1.46 Million - $1.98 Million	-77,322 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$11.86 - $21.77 $2.05 Million - $3.76 Million	-172,678 Reduced 69.07%	77,322 $1.41 Million
Q4 2020 Feb 16, 2021	BUY	$7.25 - $11.76 $1.81 Million - $2.94 Million	250,000 New	250,000 $2.89 Million

209

67.1M

216K

4.6K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.